A Slight Bounce Amidst the Fall
The U.S. stock market saw a modest rise today, with the Nasdaq Composite inching up around 10 points on this Monday.
In a stark contrast, the bears had their way as Surgery Partners, Inc. SGRY stumbled following disappointing quarterly sales figures.
Clocking in at $735.40 million, the company’s quarterly sales missed the mark, falling short of the expected $741.40 million, as per data from Benzinga Pro.
Shares of Surgery Partners took a significant hit, plummeting by 7.8% to settle at $30.43, signifying a tough day for the medical facility operator.
Adding to the woes, several other major stocks dived into the red on a day that investors would rather want to forget.
- Intuitive Machines, Inc. LUNR experienced a steep 25.1% drop to $7.18 after its lunar lander encounter with a lunar surface mishap.
- Nyxoah S.A. NYXH fell by 11.3% to $15.29 in anticipation of its upcoming financial release slated for March 5, 2024.
- Jin Medical International Ltd. ZJYL slumped by 11.2% to $6.30, adding to the downward trend.
- TransMedics Group, Inc. TMDX recorded an 8.6% dip to $75.99 ahead of its fourth-quarter financial results release.
- World Acceptance Corporation WRLD slipped by 7% to $120.71 despite a positive third-quarter financial report prior.
- MacroGenics, Inc. MGNX saw a 7% decline to $16.88 on the trading floor.
- Kosmos Energy Ltd. KOS also took a hit, shedding 7% to $5.55 following its fourth-quarter fiscal 2023 revenue report which surpassed revenue expectations.
- Orla Mining Ltd. ORLA dropped by 6.8% to $3.38, adding to the red trend for the day.
- Insulet Corporation PODD witnessed a 5.8% decline to $173.54 after Barclays revised its price target, affecting investor sentiment.
- Summit Therapeutics Inc. SMMT closed 5.6% lower at $4.38, rounding up a tough day for the equities market.
- Moderna, Inc. MRNA also succumbed to the downward push, declining by 4.3% to $92.36 following a downgrade by HSBC.
Now Read This: Top 3 Defensive Stocks That May Collapse In February
